University Medical Center New Orleans, is a 446-bed non-profit, public, research and academic hospital located in the Tulane - Gravier neighborhood of New Orleans, Louisiana, providing tertiary care for the southern Louisiana region and beyond.

There are 446 beds in University Medical Center New Orleans.

During the past decade, University Medical Center New Orleans conducted 138 clinical trials. In the 10-year time frame, 138 clinical trials started and 86 clinical trials were completed, i.e. on average, 62.3% percent of trials that started reached the finish line to date. In the past 5 years, 71 clinical trials started and 51 clinical trials were completed. i.e. 71.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Medical Center New Orleans" #1 sponsor was "National Cancer Institute (NCI)" with 54 trials, followed by "SWOG Cancer Research Network" with 32 trials sponsored, "Alliance for Clinical Trials in Oncology" with 21 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored and "Eastern Cooperative Oncology Group" with 10 trials sponsored. Other sponsors include 93 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Medical Center New Orleans" #1 collaborator was "National Cancer Institute (NCI)" with 92 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator and "Genentech, Inc." with 6 trials as a collaborator. Other collaborators include 80 different institutions and companies that were collaborators in the rest 61 trials.

According to Clinical.Site data, the most researched conditions in "University Medical Center New Orleans" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Invasive Breast Carcinoma" (8 trials), "Prostate Cancer" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Breast Cancer" (7 trials). Many other conditions were trialed in "University Medical Center New Orleans" in a lesser frequency.

Most popular intervention types in "University Medical Center New Orleans" are "Drug" (154 trials), "Other" (96 trials), "Biological" (65 trials), "Procedure" (41 trials) and "Radiation" (29 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (44 trials), "Quality-of-Life Assessment" (33 trials), "Placebo" (22 trials), "Questionnaire Administration" (22 trials) and "Paclitaxel" (21 trials). Other intervention names were less common.

The vast majority of trials in "University Medical Center New Orleans" are 178 trials for "All" genders, 34 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "University Medical Center New Orleans". undefined are not yet recruiting, 57 are recruiting, 63 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 78 completed trials in University Medical Center New Orleans, 4 suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in University Medical Center New Orleans, 5 "Phase 1" clinical trials were conducted, 62 "Phase 2" clinical trials and 127 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 12 trials that are defined as “Not Applicable".

University Medical Center New Orleans has several departments that took part in Clinical trials: "Med. Ctr. of Louisiana at New Orleans, HIV Outpatient Clinics CRS" - 8 trials, "Cancer Center at Medical Center of Louisiana - New Orleans" - 5 trials